On Pharma Importadora, Exportadora E Distribuidora De Medicamentos Ltda.

This study tests a medicine called V-IMMUNE® in about 50 people aged 2 and older who have a weak immune system (primary immunodeficiency). Participants will receive V-IMMUNE® infusions every three weeks for a year. The goal is to see if it safely reduces serious infections and im…

This study tests a medicine called V-IMMUNE® (human immunoglobulin given through a vein) to see if it can safely raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. About 31 adults and…